Is AcelRx Pharmaceuticals Inc (ACRX) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?

Friday, September 10, 2021 01:51 PM | InvestorsObserver Analysts

Mentioned in this article

A rating of 85 puts AcelRx Pharmaceuticals Inc (ACRX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AcelRx Pharmaceuticals Inc's score of 85 means it scores higher than 85% of stocks in the industry. AcelRx Pharmaceuticals Inc also received an overall rating of 41, putting it above 41% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 140 out of the 148 industries.

ACRX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on ACRX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 41 would rank higher than 41 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With AcelRx Pharmaceuticals Inc Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock is trading at $1.02 as of 1:40 PM on Friday, Sep 10, a decline of -$0.03, or -3.11% from the previous closing price of $1.05. The stock has traded between $1.01 and $1.07 so far today. Volume today is low. So far 463,945 shares have traded compared to average volume of 1,260,532 shares. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.

Share this article: